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Environmental interventions targeted at reducing indoor allergens and pollu-
tants have shown promise as a method for improving respiratory health outcomes
in children by reducing exposure in the home. However, in these interventions, it
is difficult to determine the effect of reduced exposure, a post-randomization vari-
able, on the respiratory outcomes. Using principal stratification, a framework for
calculating principal effects (i.e. effects within a stratum), we are able to measure
the effect of reduced exposure on respiratory outcomes. These principal effects
allow for the comparison of treatment effects for those who would and would not
have seen a reduction in allergen (or pollutant) levels. With the exposure reduction
variable, we can identify principal strata membership for some individuals in the
control and treatment groups. However, the observed data only allow us partial
identification of strata for other individuals. We develop a resampling based esti-
mator that incorporates the uncertainty from fitting a model (of which the ‘true’
form is unknown) to predict likely stratum membership, classifying individuals
based on this estimated probability, as well as finite sampling uncertainty. This
estimation procedure allows the model form to change to best fit the resampled
data at hand, reflecting the true uncertainty in this process.
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1 Introduction
The Guidelines for the Diagnosis and Management of Asthma published by the Na-
tional Heart, Lung, and Blood Institute have long recognized the important role the
environment plays in asthma management. These guidelines recommend reducing ex-
posure to allergens/pollutants a patient is sensitized and exposed to through the use of a
”multifacted, comprehensive approach" [5]. Their recommendations include the use of
HEPA filters, allergen-impermeable encasings for pillows and mattresses, and pest con-
trol. Despite these general guidelines, understanding the efficacy of such an approach
and its role in mediating asthma morbidity is still under study.
In recent years several clinical trials have provided evidence that reducing expo-
sure to indoor pollutants/allergens is associated with improved health outcomes among
inner-city children with asthma. However, investigators are unable to manipulate the
indoor environment directly, and instead must randomly assign participants to receive
an environmental intervention program or a control condition. The actual level of ex-
posure occurs after randomization and is thus confounded in similar ways to treatments
in observational studies. To better understand the efficacy of these interventions, we
need to estimate the effect of the intervention for the subset of patients which actually
experience a significant reduction in exposure.
Several strategies exist in the literature for stratifying on a post-treatment variable
and estimating causal effects. The method proposed here, based on the principal strat-
ification framework, randomly assigns individuals to latent classes, defined by their
potential change in exposure under the treatment and control conditions, for which they
are most likely to belong. Effects in each of these strata are then estimated using a
resampling procedure that incorporates the uncertainty introduced at each step of the
estimation. In contrast to other methods, the one proposed here incorporates the uncer-
tainty associated with the form of the model used to predict likely stratum membership.
The estimator allows this model to change form with each resampled data set, reflect-
ing the true ambiguity around the choice of baseline covariates. We believe that this
estimation procedure provides important information about the efficacy of these inter-
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ventions and will help optimize future environmental remediation programs to achieve
the largest health impact with the most efficient use of resources.
2 Literature Review
2.1 Asthma & the Environment
The Clean Air Act, passed in 1963, was the first federal legislation pertaining to the
control of air pollution levels in the United States. This act specifies that National
Ambient Air Quality standards must be set to protect the most sensitive members of the
population. Children with asthma are one such subpopulation [21]. Several studies have
been done showing that exposure to ambient air pollution is associated with increases in
asthma morbidity in this population [19, 21]. However, interventions designed to reduce
exposure to outdoor pollutants must be implemented at the national or state level and
can be extremely costly and complex. Additionally, these type of interventions can take
a long time to implement and their benefits on public health outcomes may only be
realized long after the start of implementation.
Due to the delayed effects of this type of intervention, studies have been done to
explore the associations between indoor air pollutant/allergen levels and asthma mor-
bidity in children. Studies done by Rosenstreich et al. [16], Strachan and Cook [18],
and Mortimer et al. [13] have all shown that exposure to indoor environmental allergens
and air pollutants is an important contributor to asthma morbidity among inner-city
children.1 Therefore, it is hypothesized that reducing exposure to these indoor agents,
which is relatively inexpensive, should reduce asthma morbdity among this population.
Although asthma management guidelines stress the importance of environmental con-
trol measures, there has been limited evidence of their efficacy. Several clinical trials
in the past decade have been conducted in attempt to demonstrate the efficacy of these
types of environmental interventions. We will now review selected trials whose goal
1Inner-city children have been shown to have the highest prevalence and mortality rates for asthma in
the United States [3].
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was to reduce asthma morbidity in this population through environmental remediation.
2.1.1 The Inner City Asthma Study
The Inner City Asthma Study (ICAS) was a seven-site study designed to evaluate the
effectiveness of both an environmental intervention as well as a physician feedback
intervention using a two-by-two factorial design. We will focus here only on the en-
vironmental intervention. Previous studies that looked at environmental interventions
focused on a single allergen (or pollutant). However, Morgan et al. notes that inner-city
children encounter multiple exposures each day and argue that focus should be shifted
to improving the indoor environment as a whole. Consequently, the environmental in-
tervention they implemented was multifaceted and tailored to each child’s allergen sen-
sitization. By addressing a child’s entire “environmental risk profile” they hypothesized
they could improve asthma symptoms and decrease the use of health care services [12].
Morgan et al. [12] found there was a greater reduction in asthma-related symptoms
in the intervention group compared to the control group. Additionally, significant reduc-
tions were seen in the number of disruptions to a caretaker’s plans, number of days with
lost sleep (for the child and the caretaker), and number of school days missed. Further-
more, reductions were seen in the number of unscheduled visits to the emergency room
and clinic as compared to the control group. They also found that levels of cockroach
and dust mite allergen were decreased in the homes of both the intervention and control
group participants, although this decrease was larger in the intervention group. Over-
all, they found the intervention decreased asthma symptoms among inner city children.
This decrease translated to a 34 fewer symptom days reported among the intervention
group over the 2-year study period. Another important contribution of this study was
the demonstration of sustained change (i.e. the greatest reduction in symptom days
was achieved two months after randomization and was maintained throughout the two
year study period). They concluded that environmental remediation can be used to pro-
duced sustained reductions in allergen levels and improvements in asthma-associated
morbidity.
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2.1.2 CCAUE Asthma Intervention Trial
The Johns Hopkins’ Center for Childhood Asthma in the Urban Environment (CCAUE)
conducted a randomized controlled clinical trial to test the effectiveness of home-based
interventions on reducing allergen and particulate exposure and improving the health of
the asthmatic children living there [4]. Similar to ICAS, the intervention under study
consisted of two components, physical (reducing allergen/pollutant exposure) and be-
havioral (visits from an environmental educator). Each family received a HEPA filter,
allergen-proof mattress and pillow encasings, professional pest control (for families
with evidence of an infestation or with a child sensitized to cockroach allergen), and
mouse extermination. They enrolled 100 families, with half allocated to receive the in-
tervention (those in the control group received the intervention at the end of the study).
They concluded that their intervention substantially reduced exposure to particulate
matter and cockroach allergen among inner-city children. Additionally, they saw mod-
est decreases in asthma symptoms among children in the intervention group. Among
the treatment group, 58% of children reported daytime asthma symptoms in a two-week
period at baseline. This changed to 59%, 50%, 38%, and 55% at 3, 6, 9, and 12 months,
respectively. The 6, 9, and 12 month changes represent a statistically significant reduc-
tion from baseline. In the control group 50%, 55%, 66%, 60%, and 59% of children
experienced daytime symptoms at baseline, 3, 6, 9, and 12 months, respectively. Sig-
nificant intervention effects (comparing percentages between the treatment and control
groups) were observed at 6, 9, and 12 months. Eggleston et al. hypothesized many
explanations for this “less than striking” result (as compared with ICAS results pub-
lished a year earlier). Even with only modest results in regards to asthma symptoms
(significant decreases in number of days with symptoms but no change in lung func-
tion) Eggleston et al. concluded that the intervention was effective and felt it would
be an important component in larger public health strategy to reduce symptoms among
inner-city children with asthma.
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2.1.3 Particulate Reduction Education in City Homes Study
Unlike the previous two trials reviewed, the Particulate Reduction Education in City
Homes (PREACH) study focused on reducing the exposure of children to second hand
smoke and consequently particulate matter (PM) (instead of multiple allergens and
PM)2. Like the trials that came before, the proposed intervention had both a physi-
cal and behavioral component. They provided participants in one of the intervention
arms with air cleaners (to reduce PM) and behavioral coaching promoting home smok-
ing bans. The other intervention arm received air cleaners only. These groups were
compared to each other and to a control group.
The PREACH study found a significant increase of 1.36 (SD: 4.2) symptom free
days in a two-week period among the children with air cleaners in the home compared
to a decrease of 0.24 (SD: 3.04) symptom free days in the control group. The children
in the intervention arms also saw a significant reduction in PM at 6 months. However,
even after this significant reduction, PM levels in these homes were still higher than
those of children who do not reside with a smoker (and higher than the 24-hour EPA
standard for outdoor air quality). They found that the addition of a health coach did not
provide any additional reduction in PM to just providing an air cleaner. This suggests
that an improvement in health effects is associated with a reduction in PM (due to the
air cleaner rather than a change in household smoking behavior).
2.1.4 Challenges
The studies reviewed all show that environmental interventions targeted are reducing
indoor pollutants and allergens can lead to improvements in asthma morbidity among
inner-city children. However, these studies do not allow for us to conclude that an im-
provement in the indoor environment caused the reduction in symptoms. In these stud-
ies, the reduction in pollutants/allergens occurs after randomization and is not directly
under investigator control. This allows for correlations to be observed but nothing can
be directly concluded about the causal nature of the relationship. This observed corre-
2Smoking is dominant contributor of PM [2]
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lation could imply a causal relationship between reducing allergens/pollutants and im-
proved health outcomes but this is subjected to the same kinds of confounding found in
observational studies. To begin to understand the possible causal relationship between
these variables, further statistical analysis needs to be undertaken.
Completing this additional analysis will better our understanding of the causal role
that indoor allergens/pollutants play in the reduction of asthma morbidity and the factors
that mediate the effects of environmental interventions. With a greater understanding
of how these interventions effect health outcomes we can better optimize and tailor
future interventions to achieve the maximum health benefit and to utilize resources most
efficiently. The following sections introduce existing statistical methods for estimating
causal effects after adjusting for post-treatment/randomization variables and propose a
new method for this estimation.
2.2 Adjustment for Post-Treatment Variables
The need to adjust for a variable measured after treatment assignment (or randomiza-
tion, in the case of randomized controlled studies) when that variable does not repre-
sent the outcome of interest is a common problem facing public health and medical
researchers and has been addressed previously in the literature. Before beginning to
review this literature, we will review the potential outcomes framework to illustrate and
help define the causal estimands of interest.
We consider a simple scenario in which a group of units, i = 1, 2, . . . , n, can either
be assigned to a treatment (X = 1) or the control (X = 0). The outcome of interest
will be denoted by Y and is measured at a specific time after treatment assignment
for all units. Let Yi(x) be the value of Y if unit i is assigned to treatment x. The
individual-level causal effect of X on Y is the comparison between Yi(0) and Yi(1)
(e.g. Yi(1)− Yi(0)). However, these potential outcomes are not completely observable
since we can only observe Yi(0) or Yi(1) for each i (unit).
Since we cannot estimate individual-level causal effects, we estimate the average
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treatment effect in a given population [9]. We denote this as,
δ = E[Yi(1)− Yi(0)]
Treatment assignment is strongly ignorable (i.e. treatment assignment is independent of
the potential outcomes and each individual has a non-zero probability of being assigned
to either treatment) when units are randomized to receive treatment. In randomized
controlled trials, this effect is equivalent to,
δ = E[Y |X = 1]− E[Y |X = 0]
Commonly, we wish to define this treatment effect for a subset of the population defined
by an additional covariate of interest Si measured on each unit after treatment assign-
ment (e.g. change in level of particulate matter). However, Si generally contains both
information about the unit as well as the treatment of interest. In these instances, we
are interested in the effect of X on Y after adjusting for S. We wish to estimate this in
such a way that the resulting estimate is a causal effect.
Rosenbaum [15] discussed the consequences of adjusting for a post-treatment vari-
able that has been affected by the treatment. With Si affected by the treatment, we must
again consider the potential outcomes framework. For each unit, let Si(x) be the value
of S (the post-treatment variable of interest) for unit i if assigned to treatment x. Once
again, we can only observe Si(0) or Si(1) for each individual. Rosenbaum goes on
to examine the expected difference in Yi(1) and Yi(0) after adjusting for the observed
value of Si(x). This is expressed as,
δ̃ = E[Yi(1)|X = 1, Si(1) = s]− E[Yi(0)|X = 0, Si(0) = s]
and is called the adjusted treatment difference. The quantity explored by Rosenbaum is
the net treatment difference, defined as δ̃ − δ, which is commonly discussed in attempt
to highlight the mechanism by which the treatment produces its effect. However, this
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net treatment difference is not a causal effect. The two groups of subjects, those with
a post-treatment value of s under control (Si(0) = s) and those with a post-treatment
value of s under treatment (Si(1) = s) may not be a comparable group of subjects. By
conditioning on observed values of S we introduce post-treatment selection bias in the
estimation of causal effects.
2.2.1 Defining Estimands After Stratification
To estimate causal effects, after adjusting for values of S, Frangakis and Rubin intro-
duce the principal stratification framework. Their adjustment for S always results in
causal effects because it compares potential outcomes for a common set of individuals.
Principal stratification P is defined with respect to S of i = 1, . . . , n units such that
within any set of P , all units have the same vector of potential outcomes, (Si(0), Si(1)).
Let, SPi indicate the stratum of P which the i
th unit belongs to. Thus, the estimate of
a principal effect is the comparison between {Yi(1) : SPi = s} and {Yi(0) : SPi = s}.
By conditioning on the value of S under the treatment and control condition we are
able to estimate unbiased treatment effects. These principal effects are critical for the
understanding of how treatments act on units. If these strata were known, investigators
could estimate the average principal causal effect in each stratum. However, these strata
are never completely known in practice and must be estimated.
Joffe, Small, and Hsu [11] compare and contrast several methods for both defining
and estimating effects among groups defined by a post-treatment variable (also termed
“auxiliary outcome”). In addition to the principal stratification method proposed by
Frangakis and Rubin [6], Joffe, Small, and Hsu consider stratification on a single po-
tential outcome, an observed auxiliary variable, an expected auxiliary variable, and
multiple expected auxiliary variables. Lastly, they consider a conventional approach
where subgroup membership is based solely on pretreatment covariates. For simplicity,
we will assume that S is a binary variable taking on values of 0 or 1.
For stratification on a single potential outcome we are interested in the comparison
of individuals belonging to two groups, say {Yi(1)|Si(1) = s} and {Yi(0)|Si(1) = s}.
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This is the comparison of outcomes under treatment and control conditions for indi-
viduals who have the same value of s under treatment.3 Membership in this particular
stratum is only partially observed (i.e. we cannot observe both Si(1) and Yi(0) for a
single unit i) and thus complicates causal effect estimation. Methods used for principal
effect estimation can be used here, as well as techniques for observed auxiliary variable
stratification discussed next.
When stratifying on an observed auxiliary variable, we compare {Yi(1)|S = s,X =
x} and {Yi(0)|S = s,X = x}. These are the potential outcomes under treatment and
control for individuals with the same value of S and X . Here we are conditioning
on observed values (rather than the potential outcomes) of S and X so the subgroups
are fully observable. However, these values are not able to be observed at the time
of treatment (like principal stratification and single potential outcome stratification).
Thus, effects of this nature are more explanatory (e.g. to explain differences between
treatment groups).
Another approach, expected auxiliary variable stratification, incorporates baseline
covariate information collected at the time of treatment assignment. We define the effect
for a group of individuals for whom S = 1 with a certain probability, conditioned on
baseline covariates Z and treatment assignment. We denote this probability as µx(Z) =
E(Si(x)|Z). This value, µx(Z), has been referred to as the “principal score”. We then
make comparisons between potential outcomes for individuals with the same principal
score (or with a principal score above/below some cutoff). This can be written as,
E[Yi(1)|µx(Z)]−E[Yi(0)|µx(Z)]. This can be extended to the case of expected multiple
auxiliary stratification where groups are defined by both µx(Z) and µx′(Z) where x 6=
x′.
Lastly, Joffe, Small, and Hsu [11] consider the case where strata are fully deter-
mined by baseline covariate values. The different estimands explored previously have
value in different scenarios. In practice, clinicians must prescribe the treatment they
3We could also compare {Yi(1)|Si(0) = s} and {Yi(0)|Si(0) = s}. This is the comparison of
outcomes under treatment and control conditions for individuals who have the same value of s under
control.
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believe will provide the best possible result. This decision is typically made with only
baseline covariate data in hand. Consequently, estimates stratifying on baseline covari-
ate data only may be most beneficial in these situations. However, in another scenario,
stratifying on the expected value of a post-treatment variable may be extremely use-
ful. Joffe, Small, and Hsu considers the situation in which a diagnostic test can very
accurately predict which patients will and will not develop a post-treatment auxiliary
outcome (S). Here, the treatment effect stratified by observed values of S is extremely
relevant. Another situation in which estimating the causal effect after stratifying by
a post-treatment variable is beneficial is when treatment is administered over an ex-
tended time period and the post-treatment variable is observed relatively early on. If
this variable is observed relatively quickly, treatment can be changed based on this new
information.
2.2.2 Estimating the Effect After Stratification
Joffe, Small, and Hsu [11] also reviewed estimation methods for the different estimands
described above. When stratifying on expected auxiliary variables, a simple way of
estimating this effect is to 1) estimate the expected auxiliary variable µx(Z) and 2) es-
timate the effects by level of this expected variable. The first step can be done using a
regression model (regressing S on Z, stratifying by X). The second step can be accom-
plished using standard methods under the ignorable treatment assignment assumption.
For stratification on an observed auxiliary variable, estimation is much more complex.
Joffe, et al. sketch an estimation procedure similar to G-estimation in structural nested
models when Y is continuous. The approach they outline is semiparametric and is valid
for structural distribution models. However, if Y is binary, mean models are required
and the usual logit link is needed to formulate the model.
Principal strata (PS), as defined by Frangakis and Rubin [6], are not determined
completely by observed data. Thus estimation for principal effects will be more depen-
dent on additional assumptions and restrictions. We note that the estimation techniques
used for PS can also be used for stratifcation on an observed auxilary variable or a sin-
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gle potential outcome. Since these stratification strategies focus on certain strata (rather
than all strata), we can marginalize over the unobserved levels of S after estimating
principal effects. In estimating principal effects, we generally must impose various
types of restrictions on the parameters. These are discussed in detail by Joffe, Small,
and Hsu. A Bayesian approach [10] which combines prior information with the likeli-
hood to produce a posterior and approaches based on deriving bounds on causal effects
[17] do not require such restrictions.
The principal stratification framework introduced by Frangakis and Rubin was used
by Peng et al. [14] to better understand and identify the causal role that indoor pollu-
tants play in asthma morbidity among inner city children. The treatment variable X is
defined as the assignment to an environmental intervention (X = 1) or control (X = 0).
The post-treatment variable is the experience of at least a 20 µg/m3 reduction in PM2.5
at 6 months (S = 1) or not (S = 0). Peng et al. make the monotonicty assumption
[1], excluding the group commonly referred to as the ‘defiers’. None of the exclusion
restrictions were made (see Section 3.1 for a description of these assumptions and re-
strictions).
Peng et al. took a Bayesian approach to estimating principal effects that allowed the
incorporation of existing knowledge about the effects of environmental interventions
on asthma morbidity. They modeled the outcome Yi with a normal distribution with
mean µpx and σ2p where p denotes the stratum specific parameter. Here, the outcome,
is the difference in symptom free days between baseline and 6 month follow-up. A
complete-data posterior distribution of the model parameters was constructed. Using a
Gibbs sampler, samples were drawn from this distribution to construct the full condi-
tional distributions of the parameters. The parameters of interest were the differences
in the stratum specific means, θp = µp1 − µp0. This approach allowed Peng et al. to
estimate the effect of the intervention for the subset of children who would experience
a reduction of at least 20 µg/m3 under treatment. They found that this principal effect
was much greater than the overall effect found in the original study.
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3 Compliance and Causal Inference
The clinical trials reviewed previously share a common controlled intervention: the
randomization of individuals to receive an environmental intervention or not. They
also all share a common estimand: the causal effect of randomization to a particular
treatment (i.e. the intention-to-treat effect, assignment to treatment vs. control) on
asthma symptoms after a given time. Another important estimand in these studies is
the effect of the reduction in exposure levels on asthma symptoms at a given time. This
estimand, taking into account the change in an individual’s allergen/pollutant exposure,
provides information about the efficacy of the treatment (i.e. the effect of reducing
allergen exposure). To begin to estimate this effect, we must adjust for a post-treatment
measure of compliance.
Of arguably most interest is the complier average causal effect, where compliers are
individuals for whom the intervention changes their actual treatment (i.e. who take the
treatment when assigned to the treatment arm and do not take the treatment when as-
signed to the control arm). In the framework of environmental interventions, “taking the
treatment” could be defined, for example, as experiencing a certain reduction in allergen
exposure. When administering an environmental intervention there is the possibility of
two-sided noncompliance. These two sides exist because individuals in the treatment
group can not experience a reduction in exposure and, alternatively, individuals in the
control group can experience the reduction in exposure. These noncompliers can be
divided into three distinct categories based on noncompliance behavior. Always-takers
are individuals who always receive the treatment regardless of assignment. In contrast,
never-takers are those who never receive the treatment regardless of assignment. Defiers
are those who experience the opposite of their treatment assignment, i.e., they receive




Several common assumptions are made when estimating the complier average casual
effect. First, regarding the defiers, we make the monotonicity assumption [1]. This
assumption posits that assignment to the treatment arm can only increase the probabil-
ity of receiving the treatment and thus, eliminates this specific type of noncompliance.
This appears to be a reasonable assumption in the context of these types of environ-
mental interventions. Additionally we make the stable unit treatment value assumption
(SUTVA) which assumes no interference between units (e.g. the reduction of exposure
of one individual does not affect the number of symptom free days of another indi-
vidual) [17]. This assumption also states that only one version of the treatment exists.
Third, we assume that the treatment assignment mechanism is ignorable. This is a valid
assumption in the context of randomized trials being considered here. Commonly, ex-
clusion restrictions are made as well. These restrictions state that randomization to a
treatment does not affect the outcome if it does not affect the intervention actually re-
ceived [1, 10]. This assumption translates into a null effect for the always-takers and the
never-takers described previously. We do not make this restriction here because there
is also scientific interest in the effect of these interventions that is not associated with
reduced exposure. Sizeable effect estimates in these populations would suggest that the
interventions under investigation are impacting the outcome through other mechanisms
and may spur further investigation.
4 Statistical Method
To compare treatments after adjusting for a post-treatment measure of compliance we
use the principal stratification framework developed by Frangakis and Rubin [6]. We
use S to denote the post-treatment measure of compliance. For simplicity we make
S binary, taking a value of 1 if the intervention was received and 0 if not. The strata
defined by S are called principal strata and the effects of treatment after adjusting for S
are called the principal effects. Since S is a measure of compliance, the three strata rep-
13
resent the compliers, always-takers, and never-takers (recall, we make the monotonicity
assumption described in Section 3.1).
To determine the value of S for a given individual we look at the change in allergen
exposure (or alternatively, change in PM2.5) from baseline to end of study. For example,
an individual received the treatment, S = 1, if he/she experienced a 50% or greater
reduction in allergen exposure and that he/she did not receive the treatment, S = 0, if
he/she experienced a reduction less than 50%.4 The following tree in Figure 1 illustrates
this stratification.




























As seen in Figure 1, the compliance measure, S, does not completely determine
strata membership (because of possible two-sided noncompliance). Some individuals
in both the treatment and control groups have stratum membership that is only partially
identified (e.g. an individual in the control group where S = 0 is either never-taker or
a complier). To estimate the principal effects, we must determine stratum membership
for these individuals.
To estimate the principal effect among compliers we must determine which of the
individuals in the control group for whom S = 0, and which of the individuals in
4This definition can be altered to reflect what is felt to be a clinically meaningful definition of “re-
ceiving treatment”
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the treatment group for whom S = 1, are most likely to be compliers. To do this we
calculate the probability, given S, the treatment assignment (X = 1 for treatment group,
0 otherwise), and a vector of covariates Z, that an individual is a complier.
All individuals in the control group for whom S = 0 are either never-takers or
compliers. This can be written as,
1 = P (N |X = 0, S = 0,Z) + P (C|X = 0, S = 0,Z)
Thus, by determining one of these probabilities, we can completely determine the other.
Using the rules of conditional probability we have,
P (N |X = 0, S = 0,Z) = P (N, X = 0, S = 0|Z)
P (X = 0, S = 0|Z)
=
P (N, X = 0|Z)
1− P (A |X = 0|Z)
=
P (N |X = 0|Z)P (X = 0)
1− P (A |X = 0|Z)
To estimate P (N |X = 0|Z) for each individual in the control group, we will build a
logistic regression model using the the individuals in the treatment group (where status
as never-taker or not never-taker is identified). In building this model we make the
assumption that P (N |X = 1,Z) = P (N |X = 0,Z) . This assumption holds when
treatment is randomly assigned. This regression model is constructed using baseline
covariate data only. P (X = 0) is the marginal probability of being in the control group
(e.g., 0.5 if there is equal allocation between treatment groups). The computation of
P (A |X = 0,Z) is discussed below. With the probability of being a never-taker in the
control group determined, the probability of being a complier in the control group is,
P (C|X = 0, S = 0,Z) = 1− P (N |X = 0, S = 0,Z)
Similarly, we can determine the probability of being an always-taker or a complier
in the treatment group. Again, all individuals in the treatment group for whom S = 1
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belong to one of these two groups, expressed as,
1 = P (A|X = 1, S = 1,Z) + P (C|X = 1, S = 1,Z)
Similarly, we have
P (A|X = 1, S = 1,Z) = P (A, X = 1, S = 1|Z)
P (X = 1, S = 1|Z)
=
P (A, X = 1|Z)
1− P (N |X = 1,Z)
=
P (A |X = 1|Z)P (X = 1)
1− P (N |X = 1,Z)
To estimate P (A|X = 1,Z) for each individual in the treatment group, we will build
a logistic regression model using the individuals in the control group (where status as
always-taker or not always-taker is identified). Again we make the assumption, be-
cause of the randomization of treatment assignment, that P (A|X = 0,Z) = P (A|X =
1,Z). This second model will be constructed using only baseline covariate data, as
well. P (X = 1) is the marginal probability of being in the treatment group and
P (N |X = 1,Z) is calculated using the model described previously. Consequently,
the probability of being a complier in the treatment group is,
P (C|X = 1, S = 1) = 1− P (A|X = 1, S = 1)
With the logistic regression models estimating P (A|X,Z) and P (N |X,Z), we
compute P (C|X,S,Z) and P (A|X,S,Z) or P (N |X,S,Z) for the partially identified
individuals using the formulas above. The models used to estimate these probabili-
ties are only approximations (since we do not know the true model) and only provide
a ‘best guess’ at the probability of principal stratum membership. Additionally, al-
though the control and the treatment group are “statistically” identical (i.e. they only
randomly differ), the models built to predict always-taker and never-taker status are
built using two different populations. Consequently, we may encounter scenarios when
P (A|X = 1, S = 1) > 1 or P (N |X = 0, S = 0) > 1. To avoid assigning proba-
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bilities greater than 1, we will transform the probabilities calculated using the formulas
above using a Normal cumulative density function with a mean of 0.5 and a standard
deviation of 0.35 as seen in Figure 2.
Figure 2: Transformation for Calculated Probabilities
This particular transformation was chosen because it preserves most probability val-
ues in the allowable range while still pulling in values above this range. With these
probabilities in hand, we can assign membership to the most likely principal strata and
calculate the principal effects by comparing outcomes, within strata, between the treat-
ment and control group.
4.1 Quantifying Uncertainty
If the stratum membership where known for each individual we could simply estimate
the principal effect by looking at the difference in symptom free days (the outcome) in
the treatment and control group within each stratum. However, we are estimating the
membership of the partially identified individuals and thus have added uncertainty in
our estimate that must be accounted for.
To quantify the uncertainty associated with an effect estimated in this way, a resampling-
based estimator is proposed. The following steps outline the resampling procedure:
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1. Resample, with replacement, from the original data. This is done separately in the
treatment and control group to preserve the marginal probability of being assigned
to treatment
2. Use Lasso regression models, built with baseline covariates, to estimate the prob-
ability of being an always-taker (using the individuals in the control group) or a
never-taker (using the individuals in the treatment group). Note: The L1 penalty
parameter acts as a sort of variable subset selector, allowing variables to be excluded
from the model based on the resampled data set [20].
3. Compute the probability pi of being a complier for each partially identified individ-
ual.
4. Randomly assign principal stratum membership using a Bernoulli(pi) random vari-
able
5. Calculate principal effects based on these strata assignments
6. Repeat steps 1-5 B times (B = 10, 000 is recommended)
7. Calculate the mean and desired percentiles of the bootstrapped distributions of prin-
cipal effects
By resampling from the original data and using that data to determine the ‘best’ model,
the uncertainty about the form of the model as well as finite sampling uncertainty is
incorporated in the procedure. Assigning stratum membership with a Bernoulli random
variable incorporates the additional uncertainty about stratum membership for those
partially identified individuals. Thus, the estimated mean and percentiles of the boot-
strapped distribution of effects represent plausible values for the true effect and the un-
certainty in the estimation process. Next, this method will be applied to data collected
in two randomized controlled trials of environmental interventions.
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5 Case Studies
5.1 Butz, et al.
The Particulate Reduction and Education in City Homes (PREACH) study was a three-
armed randomized controlled trial. The goal of the study was to assess the effect of
introducing air cleaners into childrens’ homes, along with a behavioral intervention
promoting home smoking bans, on asthma morbidity among inner city children. To be
eligible children must have physician diagnosed asthma and live, for at least 4 days a
week, with a smoker who smokes 5 or more cigarettes a day. The 3 arms of the trial
were 1) air cleaner only, 2) air cleaner plus health coach, and 3) control. All groups
received asthma education from a nurse during four home visits.
The pollutant targeted by the intervention was PM2.5, which has been shown to be
associated with an increase in asthma symptoms. The original study concluded that
the addition of a health coach was not associated with either a reduction in PM2.5 or
improvement in asthma symptoms. Therefore, we combine the air cleaner plus health
coach group with the air cleaner only group to create a single “treated” arm for this
secondary analysis.
The outcome of interest is symptom free days (SFD) which is defined as the number
of days, in a two week period, in which a child experiences no asthma symptoms. Butz
et al. [2] concluded that subjects in the air cleaner groups experienced larger increases
in SFDs between baseline and 6-month follow-up compared to the control group. The
air cleaner groups also saw larger decreases in PM2.5 levels from baseline to 6 months
compared to the control group. This may suggest that the treatment affected the out-
come through the lowering the PM2.5. The new method presented in Section 4 was
applied to this data set to quantify the effect of lowering PM2.5 on SFDs.
The PREACH study collected information on 126 children. However, 48 children
were missing information on PM2.5 levels at either baseline or 6 months. Without these
measurements we are unable to calculate the reduction in PM2.5 and consequently S, the
intermediate compliance variable. These 48 children were excluded from the following
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analysis. Additionally, 3 children were missing information on the baseline covariates
that are used to construct the models predicting stratum membership. These children
were also excluded, leaving 75 subjects available for analysis.
We are interested in the effect of the treatment for the compliers, the group of indi-
viduals who experience a significant decrease in PM2.5 while assigned to treatment and
do not when assigned to the control. We define a significant decrease to be 20 µg/m3
and denote this as S = 1. We begin by stratifying individuals based on their values of
S. For this data set, this can be seen in Figure 3.

























In Figure 3 individuals in the control group who experienced a significant reduction
in PM2.5 are always-takers (6). Individuals in the treatment group who did not see
a significant reduction are never-takers (33). The remaining individuals are partially
identified. We used the method described in Section 4 to classify these individuals and
calculate the corresponding principal effects.
The data was resampled, with replacement, 10,000 times. The control and treatment
arms were resampled separately to maintain the marginal probability of being assigned
to either group. Additionally, we required that at least 1 always-taker and 1 never-taker
to be in the control and treatment groups, respectively. Using the 47 individuals in the
treatment group, a lasso regression model (with a constraint of 0.5) was fit to predict
never-taker status. With the 28 individuals in the control group another lasso regression
model (with a constraint of 0.5) was fit to predict always-taker status. This was repeated
20
in each of the 10,000 resampled data sets. The baseline covariates used in both of these
models were age, a dichotomous measure of asthma severity, and baseline levels of
PM2.5 and NO2.
Using the formulas and transformation introduced in Section 4 the probability of
being a complier, pi, was computed for the 22 individuals in the control group and the
14 individuals in the treatment group that were only partially identified. Membership to
this group was assigned using a Bernoulli(pi) random variable. The outcome is change
in SFDs from baseline to 6-month follow-up. The treatment effect is the difference in
average change in SFDs between the treatment and control group within each stratum.
We note that one may wish to calculate the principal effects by fitting a regression model
in each stratum. This was not done for this data set because in some iterations certain
stratum (especially the always-takers, see Figure 5) were extremely small and fitting
this regression model would be inappropriate. However, this was done in the other case
study presented in Section 5.2.
The 10,000 principal effect estimates obtained from applying this procedure to each
resampled data set formed the bootstrap distributions of principal effects seen in Fig-
ure 4.
Figure 4: Bootstrap Distribution of PREACH Principal Effects
The red dashed line represents the mean of the distribution while the blue dashed
lines denote the 2.5% and 97.5% percentiles. Table 1 compares these estimates to the
overall treatment effect calculated by Butz et al. [2]. For the 75 individuals included in
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this analysis, the air cleaner groups experienced a 2.1 (95% CI: [0.3, 3.8]) day increase
in SFDs compared to the control group. The principal effect among the compliers (those
who would experience a reduction in PM2.5 under treatment but not under control) is
more than 1.5 times larger than this overall estimate. The principal effects among the
always-takers and the never-takers are similar in magnitude to each other (and smaller
than the complier principal effect) and have bootstrap intervals that contain 0 (indicating
a non-significant effect).
Table 1: PREACH Principal Effect Estimates
Always-Takers Compliers Never-Takers Overall
Original Analysis 2.1(0.3,3.8)
Principal Effects Analysis 1.64(-0.86,5.97) 3.63(0.64,7.60) 1.95(-0.45,4.75)
Although we posit that the strong effect found amongst the complier group is the
result of a reduction in PM2.5, it is possible that this effect may be explained by some
other covariate. Secondly, we note that the decision to dichotomize reduction in PM2.5
to create the binary compliance variable, S, is not without its limitations and draw
backs. Overall, the complier average principal effect allowed us to quantify the effect
of the intervention on the sub-population who experienced a significant reduction in
PM2.5, demonstrating that these interventions produce clinically relevant effects and
should be studied further.
There was also interest in examining how stable the stratum size was for the 10,000
resampled data sets. The proportion in each stratum was plotted, by iteration, in Fig-
ure 5. From this plot we can see that the each resampled data set contained a large
proportion of never-takers (between 35% and 77%). The next largest group, on aver-
age, was the compliers (between 5% and 53%). The smallest group was the always-
takers, which comprised between only 2% to 37% for any given sample. Given the
limited sample size (N = 75), the proportion of the compliers in each iteration of the
estimation procedure may be problematic when estimating an effect in this stratum.
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Figure 5: Proportion of Individuals per Stratum in PREACH Analysis
5.2 Morgan, et al.
The Inner-City Asthma Study used a two-by-two factorial design to explore the ef-
fect of a multifaceted, individually tailored environmental intervention and a physician-
feedback intervention on asthma symptoms and the use of asthma-related health care
services. Morgan et al. [12] found that there was no interaction between these two in-
terventions and thus their effects are considered separately. To be eligible children must
have been between 5 and 11 years of age, have physician diagnosed asthma, be resident
of a census tract in which at least 20% of households are below the poverty line, have
at least one hospitalization or two unscheduled clinic visits that were asthma related
in the last 6 months, and have a positive skin test for at least 1 of 11 indoor allergens.
This secondary analysis focused on the results of the environmental intervention (as did
Morgan et al. [12]).
Participants were randomized to either the environmental intervention arm or the
control arm. Participants in the control arm were evaluated at home visits at 6-month
intervals. The goal of the environmental intervention arm was to provide caretakers
with the information, supplies, and skills needed to implement a comprehensive envi-
ronmental remediation. This intervention was organized into 6 modules that focused
on reducing exposure to pet, dust mite, cockroach, mold, and rodent allergens. These
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interventions were tailored to the results of each participants skin test. During the 1
year intervention period, investigators conducted 5 home visits.
The original outcome of interest was maximal number of symptom days in a two
week period. The study investigators found that the maximal number of symptom days
was lower in the intervention group by 0.82 days per 2-week period. They also found
that levels of cockroach allergen (Bla g1) and dust mite allergens (Der f1 and Der p1)
were decreased in both groups over the course of the study, although greater reduc-
tions were realized in the intervention group. The original outcome was modified and
expressed as number of symptom free days (i.e. 14 - Max No. of Symptom Days) to
better align with the results of the PREACH analysis. The new method presented in
Section 4 was applied to this data set to quantify the effect of lowering allergen expo-
sure on SFDs.
The Inner-City Asthma Study enrolled 937 children at 7 possible sites (Bronx,
Boston, Chicago, Dallas, New York City, Seattle/Tacoma, and Tuscon). However, only
869 participants had at least one follow-up assessment where allergen exposure levels
and symptom information was collected. Three different sub-analyses were undertaken.
The first looked at the effect of a 50% reduction in Bla g1 for all participants. The sec-
ond looked at the effect of a 50% reduction in Bla g1 for the subset of participants that
had a positive skin test for Bla g1. Finally, the last analysis looked at the effect of a
50% reduction in an allergen exposure score.
For each of these different analyses, we were interested in the effect for the compli-
ers, the group of individuals who experienced a significant decrease in the allergen of
interest when assigned to treatment and who do not when assigned to the control. We
defined a significant decrease to be a 50% reduction in the allergen (or allergen score)
of interest and denoted this as S = 1. For each analysis only individuals with an al-
lergen measurement at both baseline and 1 year were included. A comparison between
the included and excluded individuals was undertaken in each of the three analyses.
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5.2.1 Imputation
An additional imputation step was added to the procedure described in Section 4. The
Inner-City Asthma Study investigators collected information on many baseline covari-
ates that could be used to build the always-taker and never-taker models. However, not
every individual had observed measurements for all of these covariates. Covariates with
more than 40% missingness were discarded, but for the remaining covariates multiple
imputation (MI) was undertaken. Additionally, a small amount of missingness (<10%)
was present in the outcome variable. These outcome values were imputed as well. MI
was performed with the multivariate imputation chained equations (MICE) procedure
in R, version 3.1.0. Fifty complete data sets were generated using the MICE procedure
(imputation was done separately in the control and treatment arms). 10,000 resam-
pled data sets were created by drawing 200 bootstrap samples from each of the 50 MI
datasets. This procedure is thought to propagate a comparable amount of uncertainty to
resampling from the incomplete data set and imputing the missing values 10,000 times
[8].
5.2.2 Bla g1 Reduction in Entire Sample
For the 869 individuals with at least one follow-up visit, we wished to estimate the effect
of a 50% reduction in cockroach (Bla g1) allergen (as measured on the floor) between
baseline and 1 year. Of these 869 individuals, 131 individuals were missing a Bla g1
measurement at either baseline, 1 year, or both. These individuals were excluded from
the analysis. The main demographic characteristics did not differ greatly between the
738 individuals included and the 131 excluded. However, the included individuals had
a slightly higher proportion of males (64% vs.52%) and had fewer individuals from the
New York City site (13% vs. 28%).
We begin by stratifying individuals based on their value of S. For this subset, this
can be seen in Figure 6.
In Figure 6 individuals in the control group who experienced a significant reduction
in Bla g1 are always-takers (155). Individuals in the treatment group who did not see
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a significant reduction are never-takers (179). The remaining individuals are partially
identified. The missing data was imputed and resampled as described in Section 5.2.1.
Using the 379 individuals in the treatment group and the 359 individuals in the the
control group, a lasso regression model (with a constraint of 0.5) was fit to predict
never-taker status and always-taker status, respectively. This was repeated in each of
the resampled data sets. The baseline covariates eligible for inclusion were gender,
age, race, caretaker characteristics, allergen sensitivities, asthma related symptoms, and
allergen exposure levels.
Using the formulas and transformation introduced in Section 4, the probability of
being a complier, pi was computed for the 204 individuals in the control group and the
200 individuals in the treatment group. Membership was assigned using a Bernoulli(pi)
random variable. Principal effects were estimated by fitting a linear regression model in
each stratum. This model, predicting change in SFDs, included all of the covariates used
to predict stratum membership and a treatment indicator variable. These estimates, the
coefficients of the treatment indicator variable, formed the bootstrap distributions seen
in Figure 7
The red dashed line represents the mean of the distribution while the blue dashed
lines denote the 2.5% and 97.5% percentiles. Table 2 compares these estimates to the
overall treatment effect calculated by Morgan et al. [12].
The principal effect among the compliers is 0.80 SFDs which is similar to the over-
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Figure 7: Bla g1 Reduction in Entire Sample: Bootstrap Distribution of Principal Effects
Table 2: Bla g1 Reduction in Entire Sample: Principal Effect Estimates
Always-Takers Compliers Never-Takers Overall
Original Analysis 0.82p<0.001
Principal Effects Analysis 0.64(-0.47,1.72) 0.80(-0.23,1.89) 0.83(-0.20,1.85)
Site
NY/Bos/Chi 0.62(-0.67,1.87) 0.81(-0.46,2.10) 1.01(-0.30,3.27)
Seattle -0.05(-3.36,3.09) 0.97(-2.24,4.06) -0.54(-3.32,2.20)
Southwest 1.62(-1.73,4.63) 0.62(-1.96,3.12) 1.30(-0.46,3.12)
all effect found by the original investigators. However, the confidence interval of the
estimate (as well as the intervals for the always-takers and never-takers) obtained here
is much wider. Possible explanations for these wider intervals will be discussed later.
The magnitude of effect is similar among all three strata. This may imply that our def-
inition of “receiving the treatment” may not be appropriate. Principal effects were also
examined by site (sites were grouped such that participants from New York City, the
Bronx, Boston and Chicago were in one group, participants from Seattle/Tacoma were
in another, and participants from Dallas and Tuscon made up the final group). These
were calculated with a regression model similar to the one described above, but with the
addition of a site by treatment assignment interaction term. This method was chosen to
prevent the fitting of a very large and complex model on small subgroup (e.g. never-
takers from Seattle). There appears to be heterogeneity of effects at these different
locations.
Again, we were interested in examining the stability of stratum size for the 10,000
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resample data sets. This information is plotted in Figure 8.
Figure 8: Bla g1 Reduction in Entire Sample: Proportion of Individuals per Stratum
It appears the strata stayed approximately the same size in each iteration of the
estimation procedure. The width (indicating the proportion in a given sample) seems to
be approximately equal for the never-takers, compliers, and always-takers. Combined
with the large sample size (N = 738), this would suggest there was a sufficient number
of individuals in each stratum to estimate principal effects.
5.2.3 Bla g1 Reduction in Sensitized Sample
The Inner-City Asthma Study tailored the interventions such that each participant re-
ceived a remediation plan specific to the allergens he/she was sensitized to (as indicated
by a positive skin test). Therefore, we wished to estimate the effect of a 50% reduction
in Bla g1 allergen (as measured on the floor) for the subset of individuals that were sen-
sitized to this allergen.5 Of the 869 individuals with sensitization information, 599 were
sensitized to Bla g1.6 This subset is further reduced to 494 when the 105 individuals
with missing Bla g1 measurements at either baseline, 1 year, or both were removed.
A similar analysis was undertaken to look for differences between the included and ex-
5Children sensitized to Bla g1 received professional pest control (Terminix) as part of their personal-
ized intervention.
6Only 1 child had a missing value for Bla g1 sensitization. This child was discarded.
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cluded individuals. Generally, these two groups appeared similar, however, the included
individuals had a slightly higher proportion of males (63% vs. 53%).
Again, we stratified individuals based on their value of S. For this subset, this can
be seen in Figure 9.

























The individuals in the control group who experienced a significant reduction in Bla
g1 are always-takers (103). Individuals in the treatment group who did not see a signifi-
cant reduction are never-takers (110). The remaining individuals are partially identified.
Again, the missing data was imputed and resampled as described in Section 5.2.1. The
244 control individuals and the 250 treatment individuals were used to build models to
predict always-taker and never taker status, respectively. The same baseline covariates
eligible for inclusion in the first Bla g1 analysis were used here as well.
The formulas and transformation introduced in Section 4 were used to calculate
the probability of being a complier, pi, and used to classify the 281 partially identified
individuals. The principal effects were estimated by fitting a linear regression model,
predicting change in SFDs, with all of the covariates used to predict stratum mem-
bership and a treatment indicator variable. This was done separately in each stratum.
These estimates formed the bootstrap distributions seen in Figure 10 The red dashed
line represents the mean of the distribution while the blue dashed lines denote the 2.5%
and 97.5% percentiles. Table 3 compares these estimates to the overall treatment effect
calculated by Morgan et al. [12].
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Figure 10: Bla g1 Reduction in Sensitized Sample: Bootstrap Distribution of Principal Effects
Table 3: Bla g1 Reduction in Sensitized Sample: Principal Effect Estimates
Always-Takers Compliers Never-Takers Overall
Original Analysis 0.82p<0.001
Principal Effects Analysis 0.63(-0.96,2.20) 1.28(-0.14,2.78) 0.54(-0.94,2.00)
Site
NY/Bos/Chi 1.03(-0.73,2.75) 1.51(-0.09,3.21) 0.61(-1.20,2.51)
Seattle -2.13(-9.40,5.00) -0.12(-7.14,7.51) -0.25(-5.24,5.77)
Southwest -0.17(-5.38,4.71) 0.55(-3.65,4.60) -0.43(-2.25,3.28)
The principal effect among compliers is 1.28 SFDs which is higher than the overall
estimate found by the original investigators. This seems to be intuitive, since the post-
treatment variable that was adjusted for here was targeted by the intervention in all
individuals in this subset. Again, heterogeneity of effects across sites was very evident.
(Note: Site-specific principal effects were calculated in the same manner as described
in Section 5.2.2.)
As seen in the first Bla g1 analysis, it appears the strata stayed approximately the
same size in each iteration of the estimation procedure. The width (indicating the pro-
portion in a given sample) seems to be approximately equal for the never-takers, com-
pliers, and always-takers (see Figure 11).
Although this sample was smaller, with only 494 individuals, it would appear there
was a sufficient number of individuals (between approximately 100 and 210) in each
stratum to estimate principal effects.
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Figure 11: Bla g1 Reduction in Sensitized Sample: Proportion of Individuals per Stratum
5.2.4 Allergen Exposure Score
In this last analysis, instead of focusing on the reduction of a single allergen, a com-
posite allergen exposure score was calculated. At baseline, this score is the sum of
the sensitization indicators multiplied by the floor allergen measurements of the corre-
sponding allergens. The following allergens were considered: dog (Can f1), dust mite
(Der f1 and Der p1), cat (Fel d1), and cockroach mix (Bla g1). For the ith individual,





where sij is the 0/1 indicator of sensitization to the jth allergen and m0ij is the baseline






A significant reduction, denoted S = 1, was considered to be a 50% reduction in score
between baseline and 1 year. Again, only included individuals who have an allergen
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exposure score at both baseline and 1 year. This excluded 170 (of 839) individuals.
An exploratory analysis was done to look for differences between the included and
excluded individuals. These individuals looked very similar overall. After stratifying
individuals by their value of S, we have the following strata seen in Figure 12,

























Again, the control group individuals who experienced at least a 50% reduction in
allergen exposure score are always-takers (111). Those in the treatment group that did
not experience this reduction are never-takers (193). The remaining individuals are
partially identified. Missing data was imputed and resampled in the manner described
in Section 5.2.1. Models were built to predict always-taker and never-taker status with
the control and treatment groups, respectively. The same baseline covariates used in the
two previous analyses were used here as well.
The method introduced in Section 4 was used to calculate the probability of being
a complier, pi, and was used to classify the 395 partially identified individuals. After
classification using a Bernoulli(pi) random variable, principal effects were calculated
using a linear regression model including all baseline covariates used to predict stratum
membership and a treatment assignment indicator. The following bootstrap distribution
of principal effects (i.e. the coefficients of the treatment indicator variable in the stratum
specific regression models) were estimated and plotted in Figure 13.
Once again, the red dashed line represents the mean of the distribution while the blue
dashed lines denote the 2.5% and 97.5% percentiles. Table 4 compares these estimates
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Figure 13: Allergen Exposure Score: Bootstrap Distribution of Principal Effects
to the overall treatment effect calculated by Morgan et al. [12].
Table 4: Allergen Exposure Score: Principal Effect Estimates
Always-Takers Compliers Never-Takers Overall
Original Analysis 0.82p<0.001
Principal Effects Analysis 0.72(-0.83,2.25) 0.90(-0.17,1.96) 0.92(-0.46,2.39)
Site
NY/Bos/Chi 1.46(-0.68,3.49) 1.20(-0.24,2.63) 0.96(-0.46,2.39)
Seattle -1.31(-6.79,3.77) 0.23(-3.84,4.15) 0.44(-1.98,2.91)
Southwest 0.08(-3.03,3.23) 0.71(-0.87,2.26) 1.14(-0.25,2.61)
The principal effect among compliers is estimated to 0.90 SFDs. This estimate at-
tempts to reflect the multifaceted nature of the intervention. However, the small effect
among compliers may point to the imperfect collapse of a multidimensional measure-
ment. The intervention acted on the specific allergens a participant was sensitized to,
and thus looking for a reduction in a composite measure of those allergens is an appro-
priate manner to gauge receipt of the intervention. As seen in the previous two analyses,
it appears the strata stayed approximately the same size in each iteration of the estima-
tion procedure. The width (indicating the proportion in a given sample) seems to be
approximately equal for the never-takers and compliers, while being slightly narrower
for the always-takers (see Figure 14).
Such a large proportion of compliers in each resampled dataset would indicate that
adequate data was available to calculate the effect in that stratum. Next, the result of the
33
Figure 14: Proportion of Individuals per Straturm in Allergen Exposure Score Analysis
Inner-City Asthma analyses and the PREACH analysis will be discussed in more detail.
5.3 Impact of Model Selection
We found that resampling the data, which allowed the form of the model predicting
never-taker and always-taker status to vary, introduced the greatest amount of uncer-
tainty (compared to randomly assigning stratum), especially in the case of the Inner
City Asthma Study data. For this data set, the analysis was done in two ways. First,
10,000 complete data sets were imputed and steps 2-5 described in Section 4 were re-
peated for each data set. This method only incorporated the uncertainty associated with
the imputation of the missing values. The second, (presented in Sections 5.2.2- 5.2.3)
resampled 200 data sets from 50 imputed data sets and applied steps 2-5 to each one.
This method incorporates the uncertainty from the imputation and allows the form of
the always-taker and never-taker model to vary from iteration to iteration. For the Bla
g1 analyses in the entire sample and the sensitized sample, a comparison of these two
procedures can be seen in Figure 15.
Both methods result in similar point estimates, however, the first method (seen as
the dashed lines in Figure 15) resulted in much narrower confidence intervals. This
suggests that if these models were known, much less uncertainty would surround the
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Figure 15: Estimates With and Without Model Form Uncertainty
estimate of these effects (even in the presence of missing data). Griffin, McCaffrey,
and Morral [7] examined the sensitivity of model misspecification in their approach to
estimating principal effects and found that their results were extremely sensitive when
distributions were very heavy-tailed or extremely skewed. Results were less affected
when data was skewed only moderately and tails were only ‘slightly’ heavy. This seems
to support the incorporation of additional uncertainty for the form of this model. If we
assume this is known but then misspecify the model, the resulting estimate can be very
biased and the confidence intervals will be overly optimistic.
5.4 Discussion
In the previous two cases studies our new method for predicting principal strata mem-
bership was applied to estimate the benefit of reducing indoor allergens in the homes of
asthmatic children residing in the inner-city. In the subset of children for whom aller-
gen/pollutant exposure would be reduced (by at least 20 µg/m3 in the case of PM2.5 or
by at least 50% for Bla g1/Allergen Exposure Score), an increase in symptom free days
was found which was greater than the overall effect of the intervention.
In conducting both of these case studies several points should be mentioned. First,
the selection of a single cutoff point to determine a ‘significant’ decrease in exposure
may have affected the outcome estimates in all three strata, especially for the never-
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takers. These individuals in particular may have experienced a non-trivial reduction but
were nonetheless determined to be never-takers because this reduction was below this
threshold. The dichotomization of S allowed for a much simpler and straight-forward
analysis. However, complexities may arise in interpreting the principal effects.
The PREACH study focused on a single pollutant, PM2.5, and implemented an in-
tervention (air cleaners with HEPA filters) that targeted this pollutant specifically. This
made the definition of S much simpler. Due to the multifaceted nature of the Inner
City Asthma Study intervention, determining how to define a significant reduction was
especially challenging. Morgan et al. [12] found that Bla g1 (cockroach allergen) was
reduced in both the treatment and control arms over the course of the study, however,
only children that were sensitized to Bla g1 received (or were eligible to receive) a spe-
cific module targeted at that allergen. The analyses undertaken in Section 5.2 examine
different ways to explore this effect. The first (Section 5.2.2) takes a very broad, public
health approach. This analysis estimates the effect of reducing Bla g1 by 50% for all
children, both those that are sensitized and those that are not. The second (Section 5.2.3)
takes a more targeted approach, looking at the effect of reducing Bla g1 by 50% for the
subset of individuals who are sensitized to this allergen.
Both of these approaches have limitations. Very few children enrolled in this data
set were sensitized to only Bla g1 and thus a child who saw a significant reduction in this
particular allergen may still be exposed to considerable quantities of other allergens that
trigger asthma-related symptoms. This led to the development of the “allergen exposure
score” in Section 5.2.4. This score attempts to collapse a multidimensional intervention
into a single number. Looking at the difference in this score between baseline and 1 year
attempts to capture the reduction in all allergens that a child is exposed and sensitized
to in the home and accurately quantify whether a child has ‘received’ the treatment or
not.
In all 3 analyses done with the Inner-City Asthma Study data, the proportion of
individuals in each stratum seemed stable across the 10,000 resampled data sets (see
Figures 8, 11, 14). Although the number of individuals in each stratum stayed approxi-
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mately the same, the individuals in these strata may have changed from one iteration to
the next. However, knowing that the principal effects were estimated with a larger group
of individuals provides some support for the appropriateness of the resulting estimates.
This was less true in the PREACH analysis but may be attributable to the smaller size
of the original sample.
Another consideration that must be taken into account is the choice of the lasso re-
gression constraint (applied to the L1 norm of the parameters). When this constraint is
small, more of the coefficients (as estimated by the least squares procedure) are shrunk
towards 0. When this constraint is large, fewer coefficients are shrunk towards 0, re-
sulting in a larger model. For each of the analyses undertaken constraints of 0.1, 0.5,
and 0.8 were used. For the data sets considered, all three constraints produced similar
results.
Lastly, each of the case studies presented discarded individuals that did not have
exposure levels at baseline and follow-up (6 months for PREACH, 1 year for the Inner
City Asthma Study). The resulting treatment and control groups remained balanced,
which would imply that the principal effects estimated are still valid. However, it may
affect the generalizability of the results as some differences existed between the in-
cluded and excluded individuals. Sensitivity analyses could be undertaken to assess
how these effects would differ in a more representative population.
6 Conclusion
We have introduced a new method for estimating causal effects defined by a post-
treatment variable. This method uses baseline covariate data to predict stratum member-
ship for individuals in the population whose stratum is only partially defined. Once all
individuals have been assigned to a stratum, we are able to calculate within-stratum
(“principal”) effects using simple statistical techniques. We applied this method to
data collected in two clinical trials looking at the effectiveness of environmental in-
terventions on lowering asthma morbidity among inner-city children. For the subset
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of children who would have seen a significant reduction in exposure as a result of the
intervention, we found an increase in symptom free days beyond that of being ‘random-
ized to the intervention’ (the ITT effect estimated in the original papers). This provides
evidence (with the limitations acknowledged earlier) that reducing indoor allergen/pol-
lutant exposure has a causal relationship with improving asthma symptoms in children.
The method developed in Section 4 provides an additional tool for investigators
looking to identify the effect of manipulating a single allergen or a specific group of
allergens and can possibly provide information on how to best optimize environmental
remediation plans in the future. Developing a better understanding of how these factors
contribute to the effect of applying an environmental intervention will aid in the de-
velopment of treatment guidelines and public health policy aimed at improving asthma
symptoms among inner-city children.
The estimator developed here allows for the incorporation of uncertainty at each
step of the estimation process. It also allows for easy inclusion of a multiple imputation
procedure to maximize use of baseline covariates to build the models needed to predict
stratum membership. The resulting principal effect distributions represent plausible
values for these effects. By taking the mean and 2.5% and 97.5% percentiles we are
able to report estimates and confidence intervals that capture the effect of post-treatment
variable on the outcome of interest and the associated uncertainty.
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